Source:http://linkedlifedata.com/resource/pubmed/id/11935301
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-4-5
|
pubmed:abstractText |
Veno-occlusive disease (VOD) is a life-threatening complication following allogeneic or autologous stem cell transplantation. We report on a patient with a high grade B-cell lymphoma who presented 28 days after the second autologous stem cell transplantation with weight gain, ascites, hyperbilirubinemia, and liver venules occlusion as demonstrated by sonography. Starting with high-dose methylprednisolone treatment followed by defibrotide maintenance therapy the patient showed dramatic complete response of VOD, resulting in a normal sonography of the liver and normalization of laboratory values. The response of the occlusion of nearly all liver venules underlines the value of anti-inflammatory treatment combined with new thrombolytic medication such as defibrotide for the treatment of severe VOD.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0171-5216
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
128
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
148-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11935301-Adult,
pubmed-meshheading:11935301-Anti-Inflammatory Agents,
pubmed-meshheading:11935301-Fibrinolytic Agents,
pubmed-meshheading:11935301-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11935301-Hepatic Veno-Occlusive Disease,
pubmed-meshheading:11935301-Humans,
pubmed-meshheading:11935301-Liver,
pubmed-meshheading:11935301-Lymphoma, B-Cell,
pubmed-meshheading:11935301-Male,
pubmed-meshheading:11935301-Methylprednisolone,
pubmed-meshheading:11935301-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation-- successful treatment with high-dose methylprednisolone and defibrotide.
|
pubmed:affiliation |
Klinik und Poliklinik für Innere Medizin II (Hämatologie, Onkologie, Endokrinologie und Stoffwechselerkrankungen) der Friedrich-Schiller-Universität Jena, Erlanger Allee 101, 07740 Jena, Germany. Herbert.Sayer@med.uni-jena.de
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|